Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

HEART AND HEART-LUNG TRANSPLANTATION SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT Shumway, N. E., Stinson, E. B., Oyer, P. E., Jamieson, S. W., Baldwin, J. C. 1985; 115 (45): 1571-1574

Abstract

Twenty-seven years of laboratory experience in cardiac transplantation at Stanford have provided the necessary background for a moderately successful clinical program which now extends over a period of 17 years. Heart-lung transplantation, again entirely a product of intensive laboratory research, is now ready for clinical use. Certainly much work remains to be done in the area of donor tissue preservation, particularly with respect to the lungs. It appears that new and more specific immunosuppressing drugs are on the horizon, so tissue transplantation in general will be increasingly safer. Heart transplantation has come of age, and combined heart-lung transplantation is well under way.

View details for Web of Science ID A1985ATT2600001

View details for PubMedID 3936171